Previous 10 | Next 10 |
Teleflex ( NYSE: TFX ) said the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to the Triumph Catheter, and the first clinical use of GuideLiner Coast Catheter, indicated for complex percutaneous coronary interventions The Triumph Catheter was designed in c...
WAYNE, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced key milestones in the release of two new catheters: the U.S. Food and Drug Administration (FDA) 510(k) clearance of the Triumph™ Catheter, and...
WAYNE, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 44th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 7, 2023, at 1...
WAYNE, Pa., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 23, 2023. To participate in the conference call, ...
WAYNE, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded a group purchasing organization (GPO) agreement with Premier ® , Inc. for the Titan SGS ® powered stapling device, e...
WAYNE, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of a new national advertising campaign to raise awareness of the UroLift ® System, the leading minimally invasive, outpat...
Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws. If you own Teleflex stock, would like to learn more about these claim...
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: What Moved Markets
Summary Teleflex goes into 2023 needing to prove to the Street that its 15% growth target for UroLift is still viable after multiple recent disappointments in sales growth. M&A could accelerate from here as the company has around $2B in deployable capital and a good track record of ...
WAYNE, Pa., Dec. 27, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 41st Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California, on Tuesday, January 10, 2023, at 3:00 ...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...
WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 1, 2024. To participate in the conference call, ple...
2024-07-09 10:00:05 ET Richard Newitter from Truist Financial issued a price target of $235.00 for TFX on 2024-07-09 08:48:00. The adjusted price target was set to $235.00. At the time of the announcement, TFX was trading at $211.73. The overall price target consensus is...